EGFR and cancer: As EGF-EGFR signaling has been implicated as a central channel in the development of multi-aggressive phenotypes by SCP3, we believe that inhibition of EGFR signaling may be an effective strategy to control refractory cancer, especially if there is high SCP3 expression.